Author:
Reck M.,Barlesi F.,Crinò L.,Henschke C.I.,Isla D.,Stiebeler S.,Spigel D.R.
Reference60 articles.
1. AVASTIN® (Bevacizumab). Summary of Product Characteristics;Hoffmann-La Roche Ltd,2010
2. AVASTIN® (Bevacizumab). Solution for Intravenous Infusion, US label;Genentech, Inc,2010
3. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer;Sandler;N Engl J Med,2006
4. Meta-analysis of randomized phase II/III trials adding bevacizumab to platin-based chemotherapy as first-line treatment in patients with advanced non-small cell lung cancer;Soria;Ann Oncol,2010
5. Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAiL;Reck;J Clin Oncol,2009
Cited by
82 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献